Wealth Enhancement Advisory Services »

Syndax Pharmaceuticals shares owned by Wealth Enhancement Advisory Services

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Wealth Enhancement Advisory Services from 13F filings

Historical chart of Wealth Enhancement Advisory Services investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Wealth Enhancement Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Wealth Enhancement Advisory Services

Quarter filed Position value Share count Share price at filing
2025-12-31 $411k 20k 20.34
2025-09-30 $212k 13k 16.45
2025-03-31 $162k 13k 12.29

More positions owned by Wealth Enhancement Advisory Services

Ishares Tr Core S&p500 Etf (IVV)
Broadcom (AVGO)
Ishares Tr Core Us Aggbd Et (AGG)
Alps Etf Tr Smith Core Plus (SMTH)
Microsoft Corporation (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Msci Intl Moment (IMTM)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Us Momentum (JMOM)
Schwab Strategic Tr Fundamental Intl (FNDF)
Victory Portfolios Ii Usaa Msci Usa Sm (USVM)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Ishares Tr Us Treas Bd Etf (GOVT)
Ishares Tr Msci Usa Min Vol (USMV)

View all positions for Wealth Enhancement Advisory Services

Top funds holding Syndax Pharmaceuticals

BlackRock
Kynam Capital Management
Vanguard Group
Goldman Sachs Group
Point72 Asset Management
State Street Corporation
Eversept Partners
Adage Capital Partners GP
Kingdon Capital Management
Franklin Resources
Hood River Capital Management
Soleus Capital Management
Geode Capital Management
Ensign Peak Advisors
Nuveen

View all funds holding Syndax Pharmaceuticals